Viltepso
Payments companies reported to CMS as associated with Viltepso. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Viltepso, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Viltepso
These are the largest totals companies reported as associated with Viltepso. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Kan Hor | Columbus, OH | Pediatric Cardiology | $66,358.49 |
| Peter Merkel | Radnor, PA | Rheumatology | $35,366.78 |
| John Jefferies | Memphis, TN | Advanced Heart Failure and Transplant Cardiology | $22,799.68 |
| Mathula Thangarajh | Richmond, VA | Neurology With Special Qualifications In Child Neurology | $16,971.38 |
| Michelle Figueroa | Detroit, MI | Neurology With Special Qualifications In Child Neurology | $11,399.98 |
| Jonathan Soslow | Nashville, TN | Pediatric Cardiology | $5,779.90 |
| Craig Mcdonald | Sacramento, CA | Pediatric Rehabilitation Medicine | $4,214.70 |
| Maurice Sholas | Atlanta, GA | Cardiovascular Disease | $3,855.57 |
| Stanley Nelson | Los Angeles, CA | Pediatrics | $3,219.50 |
| Toshiki Takenouchi | Okayama | $2,267.73 |
Prescribed Viltepso?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.